ORI
HZNP

Oak Ridge Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Oak Ridge Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-58,464
Closed -$6.76M – 156
2023
Q3 		$6.76M Buy
58,464
+545
+0.9% +$58.6K 0.86% 25
2023
Q2 		$5.96M Sell
57,919
-11,357
-16% -$1.2M 0.73% 38
2023
Q1 		$7.56M Sell
69,276
-2,131
-3% -$236K 1.02% 17
2022
Q4 		$8.13M Buy
71,407
+689
+1% +$57.2K 1.21% 15
2022
Q3 		$4.38M Sell
70,718
-4,118
-6% -$288K 0.66% 47
2022
Q2 		$5.97M Sell
74,836
-6,466
-8% -$612K 0.87% 26
2022
Q1 		$8.55M Sell
81,302
-16,422
-17% -$1.6M 0.95% 20
2021
Q4 		$10.5M Sell
97,724
-2,443
-2% -$267K 0.89% 29
2021
Q3 		$11M Sell
100,167
-2,035
-2% -$211K 0.97% 26
2021
Q2 		$9.57M Sell
102,202
-5,820
-5% -$536K 0.84% 34
2021
Q1 		$9.94M Buy
108,022
+28,505
+36% +$2.41M 0.93% 28
2020
Q4 		$5.82M Sell
79,517
-18,160
-19% -$1.35M 0.51% 76
2020
Q3 		$7.59M Sell
97,677
-199,269
-67% -$13.7M 0.59% 52
2020
Q2 		$16.5M Sell
296,946
-34,906
-11% -$1.49M 1.39% 15
2020
Q1 		$9.83M Sell
331,852
-32,175
-9% -$1.09M 1.01% 31
2019
Q4 		$13.2M Sell
364,027
-6,885
-2% -$211K 0.97% 38
2019
Q3 		$10.1M Sell
370,912
-30,280
-8% -$783K 0.76% 57
2019
Q2 		$9.65M Sell
401,192
-12,518
-3% -$318K 0.67% 65
2019
Q1 		$10.9M Buy
413,710
+15,883
+4% +$376K 0.7% 60
2018
Q4 		$7.77M Buy
+397,827
New +$7.8M 0.56% 69

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oak Ridge Investments's HZNP Position: Q4 2023 in Review

Oak Ridge Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 58,464 shares — an estimated $6.76M sold.

Oak Ridge Investments first reported a position in HZNP in Q4 2018 and held it in 20 quarters. The position peaked at $16.5M in Q2 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Oak Ridge Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Oak Ridge Investments sold 58,464 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.76M.
  • Oak Ridge Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • Oak Ridge Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16.5M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Oak Ridge Investments's 13F filing for Q4 2023, filed 16 Jan 2024.